News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Danaher CEO’s Total Compensation For 2009 Increased 42% From 2008
April 6, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DOW JONES -- Danaher Corp. (DHR) Chief Executive Lawrence Culp's total compensation for 2009 rose 42%, despite a 13% drop in net income last year for the diversified manufacturer because of difficult business conditions.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Danaher
MORE ON THIS TOPIC
Earnings
Roche Plans To Go Toe-to-Toe With Novo, Lilly in Obesity
January 29, 2026
·
2 min read
Layoff Tracker
Gilead Continues California Cuts With 34 Laid Off
January 29, 2026
·
47 min read
·
BioSpace Editorial Staff
Insights
Biotech’s New Cycle, JPM Deal Hype and Where Alpha Still Hides
January 29, 2026
·
1 min read
·
Jennifer Smith-Parker
Manufacturing
BMS-Partnered Cellares Raises $257M for Cell Therapy Manufacturing Expansion
January 28, 2026
·
2 min read
·
Nick Paul Taylor
